Elevated MMP-2 [5,94] and MMP-9 [95] levels in patient tissue samples, serum, or cerebrospinal fluid (CSF) have been associated with advanced tumor grades, an increased risk of recurrence, and lower overall survival. Here, MMP9 is linked to neoplasm.